Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
 
Articles by E. Mayisvren
Total Records ( 2 ) for E. Mayisvren
  G. Senthilvel , M. Jegadeesan , Anoop Austin , P. Thirugnanasambantham , E. Mayisvren , M. Balasubramanian , N. Narayanan and S. Viswanathan
  Diarun plus was evaluated for its therapeutic antihyperglycemic activity in streptozotocin-induced diabetes in animal models. It was effective in controlling hyperglycemic status in rats and mice. The drug (500 mg/kg) showed significant antidiabetic property as judged by serum glucose levels. However, it did not significantly influence the levels of serum insulin in both diabetic and normoglycemic rats. This is a promising drug to develop standardized phytomedicine for diabetes mellitus. The findings suggest that it can be considered as a therapeutic agent, wherever elevated glycemic status is observed.
  Anoop Austin , G. Senthilvel , P. Thirugnanasambantham and E. Mayisvren
  Hyperlipidemia is one among the risk factors affecting normal health. Though various hypocholesteremic agents are available, they are having their own limitations. Arogh is a scientifically validated polyherbal Instant Formulation indicated for hypercholesteremia, stress, cardiac ailments and Obesity. This study is focused as a randomized clinical study in treating hyperlipidaemia. Arogh was found to effectively reducing total cholesterol, triglycerides and LDLc levels and increased TC/HDLc ratio HDLc levels. This helps preventing atherosclerosis and reduces the risk of CHD.
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility